from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1607/chaA

LFCtreatmentdescriptionclass of inhibitor

-0.576

Amikacinug/mL Amikacintranslation

-1.524

Cap5-10ug/mL Capreomycintranslation

-1.498

Rox10-50 ug/mL Roxithromycintranslation

0.065

SM2-5 ug/mL Streptomycintranslation

-1.667

Tet5-10 ug/mL Tetracyclinetranslation

1.330

Rif0.2-5ug/mL Rifampicintranscription

-0.340

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.395

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.245

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.045

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.381

Clofazimine10-13 ug/mL Clofaziminerespiration

0.134

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.960

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.125

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.703

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.073

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.629

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.415

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.929

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.616

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.339

KCN5-20 ug/mL Potassium cyaniderespiration

1.228

NaN30.2-2 mM Sodium aziderespiration

-0.492

Nigericin50 uM Nigericinrespiration

-0.102

TRC10-150 ug/mL Triclosanrespiration

-1.630

TRZ10-25 ug/mL Thioridazinerespiration

0.077

Valinomycin0.5-10 uM Valinomycinrespiration

0.131

ZnSO42 mM ZnSO4respiration

-0.258

menadione6-10 ug/mL Menadionerespiration

0.018

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.039

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.218

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.189

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.585

NRP_1Non-replicating persistence stage 1dosRassociated

0.331

Amp0.2mg/mL AmpicillincellWall

0.521

Cephalexin20-100 ug/mL CephalexincellWall

0.360

Cerulenin0.32-5 ug/mL CerulenincellWall

1.054

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.400

EMB10-20 ug/mL EthambutolcellWall

0.131

Eta12-40 ug/mL EthionamidecellWall

0.161

INH0.2-0.4 ug/mL IsoniazidcellWall

0.667

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.310

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.590

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.062

BZA0.12 mg/mL BenzamidearomaticAmides

0.518

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.415

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.396

H2O24 mM hydrogen peroxideDNAdamaging

-0.273

Levo10 ug/mL LevofloxacinDNAdamaging

0.158

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.905

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.795

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.359

UVUV-irradiationDNAdamaging

-0.781

ARP41-4 ug/mL Antitubercular compound ARP4?

0.781

Antimycin12.5-50 ug/mL Antimycin A?

0.236

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.771

PA_110-50 ug/mL Antitubercular compound PA-1?

0.800

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.254

PA8240.2-2 ug/mL PA-824?

0.339

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.702

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.180

Verapamil50 uM Verapamil?

-0.219

mercaptoethanol2 mM 2-Mercaptoethanol?

0.408

methoxatin10-20 ug/mL Methoxatin?